Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer

The use of conventional methods for the treatment of cancer, such as chemotherapy or radiotherapy, and approaches such as brachytherapy in conjunction with the unique properties of nanoparticles could enable the development of novel theranostic agents. The aim of our current study was to evaluate th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Molecules (Basel, Switzerland) Switzerland), 2024-02, Vol.29 (5)
Hauptverfasser:	Salvanou, Evangelia-Alexandra, Kolokithas-Ntoukas, Argiris, Prokopiou, Danai, Theodosiou, Maria, Efthimiadou, Eleni, Koźmiński, Przemysław, Xanthopoulos, Stavros, Avgoustakis, Konstantinos, Bouziotis, Penelope
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Ferric oxide Health aspects Iron compounds Nanoparticles
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!